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Tuberculosis is a disease caused by Mycobacterium 
tuberculosis. The bacterial cell wall has a characteristic 
low permeability, which essentially makes antibiotics 
ineffective. The cell wall material must be regulated so 
that its deposition does not compromise its structure. 
In this study, two new inhibitors, 2-amino-4-(4-
cholorophenyl)-5,6,7,8,9,10-hexahydrobenzo[8] an-
nulene-1,3,3(4H)-tricarbonitrile(Ia) and 2-amino-4-(4-
bromophenyl)-5,6,7,8,9,10-hexahydrobenzo[8]
annulene-1,3,3(4H)-tricarbonitrile(Ib) were synthe-
sized. The crystal structures of the above compounds 
were determined by single crystal X-ray diffraction. 
The compounds C21 H19 Cl N3 (Ia) and C21 H19 Br N3 
(Ib) were crystallized in the monoclinic and triclinic 
system. In both compounds, the cyclohexane ring was 
found to adopt a boat conformation. The cyclooctane 
ring of both compounds adopted a twisted chair-chair 
conformation.  In silico analyses revealed that both 
compounds showed good anti-mycobacterial activities 
against the enoyl-acyl carrier enzyme and the N-acetyl
-gamma protein, both of which are critical for bacterial 
survival. Synthesis, structure determination, conforma-
tion, intra, inter-molecular interactions and docking 
studies of both compounds are presented herein. 
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Introduction 
 
Tuberculosis (TB) is an infection caused by slow-
growing bacteria and remains a leading cause of hu-
man suffering and death (Tiruviluamala et al. 2002, 
Smith 2003, Schluger et al. 2005). Mycobacterium 
tuberculosis has a unique membrane structure com-
posed largely of lipids that have long-chain fatty acids, 
called mycolic acids. 
 The enoyl-acyl carrier protein reductase en-
zyme (InhA) catalyzes the NADH-dependent reduction 
of unsaturated, long chain, β-branched fatty acids 
(mycolic acids), which are essential for bacterial cell 
wall synthesis. Mycobacterium tuberculosis InhA is a 
fundamental target for anti-tuberculosis intervention 
(Bradford et al. 1998, Dessen et al. 1995, Rozwarski et 
al. 1998). Inhibition of the enzyme leads to an in-
creased bacterial vulnerability to external oxidative 
attacks and ultimately to bacterial death. 
 The enzyme N-acetyl-gamma-glutamyl-
phosphate reductase (AGPR) catalyzes the nicotina-
mide adenine dinucleotide phosphate (NADPH)-
dependent reductive dephosphorylation of N-acetyl-
gamma-glutamyl-phosphate to N-acetylglutamate-
gamma-semialdehyde. This reaction is the third step in 
the argentine-biosynthetic pathway (Cybis & Davis 
1975) that is essential for some microorganisms and 
plants, and in particular for Mycobacterium tuberculo-
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Figure 1. Chemical diagram of the molecule (Ia) (A) and 
(Ib) (B). 
A B 
sis. Inhibition of this protein leads to inhibition of the 
argentine biosynthesis. 
 Isoniazid is a narrow spectrum anti-
mycobacterial agent. Activated isoniazid causes inhibi-
tion of mycolic acid synthesis. A series of 2-
benzylsulfanyl derivatives of benzooxazole and ben-
zothiazole have shown their anti-mycobacterial activ-
ity against Mycobacterium tuberculosis (Koci et al. 
2002).  Sanna et al. (2000) synthesized a series of aryl 
substituted-[1H(2H)benzotriazol-1(2)-yl]acrylnitriles 
and have also reported anti-mycobacterial activity of 
the latter. The emergence of multi drug resistant TB 
(MDR-TB) and extensively drug resistance (XDR-TB) 
makes the treatment ineffective. The drug resistant and 
HIV co-infection have resulted in the need for new anti
-tuberculosis drugs. Continuing our work in develop-
ing new drug-like agents for Mycobacterium tubercu-
losis (Nagalakshmi et.al. 2014, Suresh et al. 2012, 
Vishnupriya et al. 2014), two new benzo[8]annulene 
compounds were synthesized. The structures of both 
compounds were studied using single crystal X-ray 
diffraction. Here we report the synthesis and single 
crystal X-ray studies of 2-amino-4-(4-cholorophenyl)-
5,6,7,8,9,10-hexahydrobenzo[8]annulene-1,3,3(4H)-
tricarbonitrile (Ia) and 2-amino-4-(4-bromo phenyl)-
5,6,7,8,9,10-hexahydrobenzo[8]annulene-1,3,3(4H)-
tricarbonitrile (Ib) (Figure 1) together with docking 
studies. 
 
Materials and Methods 
 
Preparation of compound (Ia) 
A mixture of cyclooctanone (1 mmol), 2-choloro ben-
zaldehyde (1 mmol) and malononitrile (2 mmol) was 
solvated in ethanol to which NaOEt (0.5 mmol) was 
added. All chemicals were purchased from Sigma-
Aldrich (St. Louis, MO) and were used without further 
purification. The reaction mixture was heated under 
reflux for 2–3 hours. As soon as the  completion of the 
reaction was confirmed by thin layer chromatography, 
the remaining solid mater was filtered and dried. The 
solid was then crystallized from ethyl acetate, which 
yielded colorless crystals. The melting point was 470 
K and yield was 85%. 
 
Preparation of compound (Ib) 
A mixture of cyclooctanone (1 mmol), 4-bromo ben-
zaldehyde (1 mmol) and malononitrile (2 mmol) was 
taken in ethanol to which NaOEt (0.5 mmol) was 
added. The reaction mixture was heated under reflux 
for 2-3 hours. As soon as the completion of the reac-
tion was confirmed by thin layer chromatography, the 
remaining solid mater was filtered and dried. The solid 
was then crystallized from ethyl acetate, which yielded 
colorless crystals. The melting point was 461 K and 
yield was 85%. 
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Figure 2. The molecular structure of compounds (Ia) (A) and (Ib) (B), showing the atom numbering scheme. Displacement 
ellipsoids are drawn at 30% probability level, using Platon (Spek 2008).  
A B 
Structure Determination and Refinement 
X-ray diffraction intensity data were collected for 
compounds (Ia) and (Ib) on the Bruker Smart Apex II 
single crystal X-ray diffractrometer, equipped with 
graphite mono-chromated (MoKα) λ=0.7103 Å radia-
tion and CCD detector. Crystals were cut to a suitable 
size and mounted on a glass fibre using cyanoacrylate 
adhesive. The unit cell parameters were determined 
from 36 frames measured (0.5° ω and φ scans) from 
three different crystallographic zones, using the 
method of difference vectors. The intensity data collec-
tion, frames integration, Lorentz-Polarization correc-
tion and decay correction were performed using SAINT 
(Bruker 2004). Empirical absorption correction multi-
scan was performed using the SADABS (Bruker 2004) 
program. The crystal structures of both compounds 
were obtained by direct methods using SHELXD2013. 
The structures were refined by the full-matrix least-
squares method using SHELXL2013 (Sheldrick 2008). 
All non-hydrogen atoms were refined using anisot-
ropic temperature factors. The final difference Fourier 
maps for all compounds at this stage were critically 
inspected and the hydrogen atoms were located and 
included in the refinement, only with isotropic tem-
perature factors. The accuracy of the crystal structures 
was evidenced from the final residual R- and wR- fac-
tors and other parameters including estimated standard 
deviations in the values of bond length and bond an-
gles, ‘data-to-parameter’ ratio, etc. Details of the crys-
tal data, data collection and refinement are given in 
Table 1.   
 
Docking studies 
The coordinates of enoyl acyl carrier protein (2NSD) 
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Empirical formula C21 H19 Cl N4 C21 H19 Br N4 
Formula weight 362.85 407.31 
Temperature 293(2) K 293(2) K 
Wavelength 0.71073 Å 0.71073 Å 
Crystal system /
space group 
Monoclinic/ 
P21/c 
Triclinic/ P-1 
Unit cell  
Dimensions 
a = 13.630(11) Å a = 7.4208(5) Å 
b = 10.475(8) Å b = 10.160(6) Å 
c = 13.8690(4) Å c = 13.955(8) Å 
α = 90° α = 70.635(3)° 
β = 107.403(2)° β = 77.70(3)° 
γ  = 90° γ = 87.80(3)° 
Volume 1889.6(3) Å3 969.35(11) Å3 
Z/ Density 
(calculated) 
4/ 1.275 mg/m3 2/1.395 mg/m3 
Absorption  
coefficient 
0.214 mm-1 2.132 mm-1 
F(000) 760 416 
Crystal size 
0.21x0.19 x0.18 
mm3 
0.20 x 0.19 x 
0.17 mm3 
Theta range for 
data collection 
2.48 to 30.17°. 2.81 to 25.49°. 
Limiting indices 
-19<=h<=19, 
-14<=k<=14, 
-16<=l<=19 
-8<=h<=8, 
-12<=k<=12, 
-16<=l<=16 
Reflections  
collected 
25664 19116 
Independent  
reflections 
5443 [R(int) = 
0.0363] 
3591 [R(int) = 
0.036] 
Completeness to 
theta = 25.50° 
99.9 % 99.9 % 
Refinement 
method 
Full-matrix least
-squares on F2 
Full-matrix least
-squares on F2 
Data / restraints / 
parameters 
5443 / 2 / 235 3591 / 1 / 235 
Goodness-of-fit 
on F2 
1.025 1.05 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0491, 
wR2 = 0.1068 
R1 = 0.0534, 
wR2 = 0.1252 
R indices  
(all data) 
R1 = 0.0898, 
wR2 = 0.1280 
R1 = 0.0926, 
wR2 = 0.1425 
Largest diff. peak 
and hole 
0.214 and -0.303 
e.Å-3 
0.782 and -1.342 
e.Å-3 
Table 1. The crystal data, intensity data collection and struc-
ture solution and structure refinement parameters of com-
pounds (Ia) and (Ib). 
A 
B 
Figure 3: The inversely related molecules forms a ring mo-
tif R2
2(12) which are linked through Van der Waal’s interac-
tions. A, compound (Ia); B, compound (Ib). 
with Nad and N-acetyl-gamma-glutamyl-phosphate 
reductase (2NQT) were retrieved from the RCSB pro-
tein data bank (http://www.pdb.org). The target protein 
of 2NSD contains two monomers. Only one monomer 
was selected for docking analysis. The protein struc-
tures were cleaned using the whatif online server 
(http://swift.cmbi.ru.nl/whatif/). The protein’s active 
site pocket was identified using ‘Computed Atlas of 
Surface Topography’ (http://sts.bioe.uic.edu/castp/). 
Preparation of protein and ligand input structures and 
the definition of the binding sites were carried out un-
der a GRID-based procedure. A rectangular grid box 
was constructed over the protein with grid points 
90X90X90 Å3 separated by 0.375 Å under the docking 
procedure. The lowest energy cluster returned by 
AutoDock for each compound was considered and 
used for further analysis. Consequent runs were set up 
to 100 for each inhibitor. All other parameters were 
maintained at their default settings. All the docking 
result visualizations are achieved by using the 
‘PDBsum Generate’ online server (https://
www.ebi.ac.uk/pdbsum/). 
 
Results 
 
The molecular structures of compounds (Ia) and (Ib) 
are shown in Figure 2. The two compounds differ in 
the nature of the substituent at position 2 and 4 of the 
phenyl ring. This simple change in the structures re-
sults in the change of structure types. In both com-
pounds, the cyclohexane ring adopts a boat conforma-
tion with puckering parameters Q = 0.445(17) Å, Ѳ = 
65.5(2)° and Φ = 39.4(2)° in compound (Ia); Q = 0.406
(4) Å, Ѳ = 115.6(6)° and Φ = 210.4(7)° in compound 
(Ib). The cyclooctane ring adopts a twisted chair-chair 
conformation in compounds (Ia) and (Ib) as found in 
related structures (Fun et al. 2010, Suresh et al.  2007). 
The triple-bond characters of  C13 ≡ N1, C14 ≡ N2 
and C15 ≡ N3  [1.138(2) Å , 1.131(2) Å, 1.129(2) Å in 
compound (Ia) and  1.137(5) Å , 1.126(5) Å, 1.127(5) 
Å in compound (Ib), respectively]  as well as the bond 
angles of C4-C13≡N1,  C2-C14≡N2 and C2-C15≡N3  
[179.2(2)° , 178.5(2)°, 178.2(2)° in compound (Ia) and 
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D-HA d(D-H) ...d(HA) ...d(DA) <DHA 
C1-H1-Cl1 0.98 2.54 
3.087
(15) 
115 
N4-H4A-N1 (i) 0.86 2.16 3.015(2) 170 
Table 2. Hydrogen bonds [Å and °] of compound (Ia). Sym-
metry transformations used to generate equivalent atoms: (- 
x, - y, - z). 
D-HA d(D-H) ...d(HA) ...d(DA) <DHA 
N4-H4A-N1 (i) 0.86 2.13 2.974(5) 169 
Table 3. Hydrogen bonds [Å and °] of compound (Ib).  
Symmetry transformation used to generate equivalent at-
oms: (1 - x, 1 - y, -z). 
Figure 4: Enoyl acyl carrier protein with Nad interactions for compound (Ia) (A) and (Ib) (B). 
A 
B  
 
179.2(5)°, 178.9(4)°, 178.7(4)° in compound (Ib), re-
spectively] in both compounds define the linearity of 
the cyano carbonitrile compounds. The phenyl sub-
stituent of the cycloheaxne ring at C1 has a negative 
synclinal conformation in compound (Ia) and negative 
anticlinal conformation in compound (Ib), as evi-
denced by the C2–C1–C21–C22  [-83.67° in com-
pound (Ia) and -112.5° in compound (Ib) torsion an-
gles]. The aryl ring in the structure (Ib) is not coplanar 
with the mean plane of the cyclohexane ring. This lack 
of coplanarity is caused by non-bonded interactions 
between one of the ortho H atoms in the aryl ring and a 
hydrogen atom at the C1 position of the cyclohexane 
ring. Steric repulsions are reduced by the expansion of 
the C1–C21– C26 angle in structure (Ib). 
 
Crystal packing 
Inter molecular hydrogen bond geometry of compound 
(Ia) and compound (Ib) are listed in Table 2. In the 
crystal structure of compound (Ia) the N4 atom of the 
cyclohexane ring is involved in the intermolecular in-
teraction N4—H4A···N1(i) with the N1 atom (Table 
2). This forms a R2
2(12) ring motif (Bernstein et al. 
1995) [symmetry code: (i) (- x, - y,  – z)]. These adja-
cent ring motifs are linked together via Van der Waal’s 
interactions as shown in Figure 3. 
 In the crystal structure of the compound (Ib) 
the intermolecular interaction N4—H4A···N1(i) (with 
the N1 atom) (Table 2) forms a R2
2 ring motif (12) 
(Bernstein et al. 1995) [symmetry code: (i) (2 - x, 1 - 
y, – z)]. These adjacent ring motifs are linked together 
by van der Waal’s interactions, as shown in Figure 3. 
 The N—N distance is longer in compound (Ia) 
[3.015(2) Å] compared to (Ib) [2.974(5) Å] and the 
N—H···N angle in compounds (Ia) and (Ib) are 169° 
and 170°, respectively. This shows that the 4-bromine 
substituent forms a stronger hydrogen bond than the 2-
cholorine substituent. 
 
Docking analysis 
The target protein structure of 2NSD with Nad was 
docked with the synthesized compounds using Auto-
Dock4v2 (Goodsell 1998). The synthesized com-
pounds were found to display good binding affinity to 
the receptor with minimum binding energy equal to -
9.47 and -10.70 for (Ia) and (Ib), respectively. The Nad 
interactions of the compounds are shown in Figure 4. 
In compound (Ia), the nitrogen atom of the 
benzo ring is hydrogen bonded to MET199, one of the 
catalytic residues in the InhA active site, as shown in 
Figure 4. Rozwarski et al. (1999) have shown that hy-
drophobic aminoacids of the loop are important for 
proper substrate binding into the cavity. Interestingly, 
the last few carbon atoms of the fatty acid interact with 
the hydrophobic amino acids Ala198, Met199, and Ile202. 
Our (Ia) inhibitor is able to directly interact with one 
of these residues (Met199), leads to a defined loop 
structure and has hydrophobic interactions to the im-
portant loop residues of  InhA, resulting in a slow tight 
binding inhibition. In our (Ib) compound, the nitrogen 
atom of the benzo ring is hydrogen bonded to Ile215, 
one of the catalytic residues in the InhA active site and 
has hydrophobic interactions with Ala198 and Met199, as 
shown in Figure 5. 
The target protein structure of 2NQT was 
docked with the synthesized compounds using Auto-
Dock4v2 (Goodsell, 1998). The synthesized com-
pounds were found to display good binding affinity to 
Journal of Molecular Biochemistry, 2016   37 
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Figure 5. Interactions of compound (Ia) (A) and (Ib) (B) with protein. 
the receptor with minimum binding energy equal to -
6.25 and -7.18, for compounds (Ia) and (Ib), respec-
tively. 
In compound (Ia), the nitrogen atom of the 
benzo ring is hydrogen bonded to His90, where as in 
compound (Ib), the ligand has hydrophobic interac-
tions with the protein (Figure 6). 
 
Conclusion 
 
Our goal is to propose new TB inhibitors. In this direc-
tion, we synthesized two novel compounds of benzo-
annulene derivatives. The compounds were docked 
with the enoyl-aceyl carrier protein and the N-acetyl-
gamma-glutamyl-phosphate reductase. Their free bind-
ing energies were evaluated. Both compounds showed 
good binding affinity, which is indicative of stable, 
energetically viable complexes. Hence, our synthe-
sized ligands bear promising in silico anti-tubercular 
activities. From the docking analysis of the two com-
pounds with both protein receptors, it was found that 
(Ib) shows better binding with the receptors, as com-
pared to (Ia). 
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